NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Open Access
- 27 May 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 115 (21), 4293-4301
- https://doi.org/10.1182/blood-2009-05-222190
Abstract
Natural killer (NK) cells suppress graft-versus-host disease (GVHD) without causing GVHD themselves. Our previous studies demonstrated that allogeneiThis publication has 40 references indexed in Scilit:
- Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow TransplantationThe Journal of Immunology, 2009
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityBlood, 2008
- Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsBlood, 2008
- Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysisBlood, 2007
- Hematopoietic Stem-Cell TransplantationThe New England Journal of Medicine, 2006
- NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptorsBlood, 2005
- In vivo imaging of graft-versus-host-disease in miceBlood, 2004
- A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunityEuropean Journal of Immunology, 2003
- NK cell functions restrain T cell responses during viral infectionsEuropean Journal of Immunology, 2001
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.The Journal of Experimental Medicine, 1995